Does Dr. ROBERT LEWANDOWSKI have financial conflicts of interest?

Dr. ROBERT LEWANDOWSKI (MD) has received a total of $810,123 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $804,010 in personal promotional payouts (consulting, meals, travel) and $6,112 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBERT LEWANDOWSKI?

According to CMS Open Payments data, Dr. ROBERT LEWANDOWSKI received funding from BARD PERIPHERAL VASCULAR ($278,643), TRISALUS LIFE SCIENCES ($261,196), and BOSTON SCIENTIFIC CORPORATION ($109,152).

Does Dr. ROBERT LEWANDOWSKI receive research grants or speaking fees?

Dr. ROBERT LEWANDOWSKI has received $804,010 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $6,112 in clinical research grants.

DR. ROBERT LEWANDOWSKI

MDReal-Time Hydrated

Specialty: Radiology, Vascular & Interventional Radiology

Practice Location: CHICAGO, IL 60611

NPI Number: 1689618761

LIFETIME INDUSTRY VALUE

$810,123

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. LEWANDOWSKI is a verified Radiology, Vascular & Interventional Radiology practitioner based in CHICAGO, IL.

Between 2021 and 2025, Dr. LEWANDOWSKI had an overall industry promotional and research financial footprint of $810,123 as recorded in the federal CMS Open Payments database.

$804,010 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$6,112 was allocated to sponsored clinical trials and medical research activities.

Dr. LEWANDOWSKI's primary funding source is BARD PERIPHERAL VASCULAR, which accounts for $278,643 (representing 34.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BARD PERIPHERAL VASCULAR

Rank 1

$278,643

34.4%

TRISALUS LIFE SCIENCES

Rank 2

$261,196

32.2%

BOSTON SCIENTIFIC CORPORATION

Rank 3

$109,152

13.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.